{"id":"https://openalex.org/W3045571047","doi":"https://doi.org/10.1111/dom.14153","title":"Combination therapy with pioglitazone/exenatide improves beta\u2010cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3\u2010 year follow\u2010up of the Qatar study","display_name":"Combination therapy with pioglitazone/exenatide improves beta\u2010cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3\u2010 year follow\u2010up of the Qatar study","publication_year":2020,"publication_date":"2020-07-30","ids":{"openalex":"https://openalex.org/W3045571047","doi":"https://doi.org/10.1111/dom.14153","mag":"3045571047","pmid":"https://pubmed.ncbi.nlm.nih.gov/32729222"},"language":"en","primary_location":{"id":"doi:10.1111/dom.14153","doi":"https://doi.org/10.1111/dom.14153","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.14153","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005726509","display_name":"Muhammad A Abdul\u2010Ghani","orcid":"https://orcid.org/0000-0003-4556-1787","observed_orcids":["https://orcid.org/0000-0003-4556-1787","https://orcid.org/0000-0003-2165-695X"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I4210165735","display_name":"Dasman Diabetes Institute","ror":"https://ror.org/05tppc012","country_code":"KW","type":"education","lineage":["https://openalex.org/I4210165735"]}],"countries":["KW","US"],"is_corresponding":true,"raw_author_name":"Muhammad Abdul\u2010Ghani","raw_affiliation_strings":["Dasman Diabetes Institute, Kuwait City, Kuwait","Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"],"raw_orcid":"https://orcid.org/0000-0003-4556-1787","affiliations":[{"raw_affiliation_string":"Dasman Diabetes Institute, Kuwait City, Kuwait","institution_ids":["https://openalex.org/I4210165735"]},{"raw_affiliation_string":"Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079737198","display_name":"Osama Migahid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103132","display_name":"Hamad General Hospital","ror":"https://ror.org/01bgafn72","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210103132"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Osama Migahid","raw_affiliation_strings":["Academic Health System, Hamad General Hospital, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Health System, Hamad General Hospital, Doha, Qatar","institution_ids":["https://openalex.org/I4210103132","https://openalex.org/I49828101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019449306","display_name":"Ayman Megahed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103132","display_name":"Hamad General Hospital","ror":"https://ror.org/01bgafn72","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210103132"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Ayman Megahed","raw_affiliation_strings":["Academic Health System, Hamad General Hospital, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Health System, Hamad General Hospital, Doha, Qatar","institution_ids":["https://openalex.org/I4210103132","https://openalex.org/I49828101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091912602","display_name":"Ralph A. DeFronzo","orcid":"https://orcid.org/0000-0003-3839-1724","observed_orcids":["https://orcid.org/0000-0003-3839-1724","https://orcid.org/0000-0002-8581-6273"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph A. DeFronzo","raw_affiliation_strings":["Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"],"raw_orcid":"https://orcid.org/0000-0003-3839-1724","affiliations":[{"raw_affiliation_string":"Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026797635","display_name":"Ebaa Al\u2010Ozairi","orcid":"https://orcid.org/0000-0001-5006-4369","observed_orcids":["https://orcid.org/0000-0001-5006-4369"]},"institutions":[{"id":"https://openalex.org/I4210165735","display_name":"Dasman Diabetes Institute","ror":"https://ror.org/05tppc012","country_code":"KW","type":"education","lineage":["https://openalex.org/I4210165735"]}],"countries":["KW"],"is_corresponding":false,"raw_author_name":"Ebaa Al\u2010Ozairi","raw_affiliation_strings":["Dasman Diabetes Institute, Kuwait City, Kuwait"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dasman Diabetes Institute, Kuwait City, Kuwait","institution_ids":["https://openalex.org/I4210165735"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011988774","display_name":"Amin Jayyousi","orcid":"https://orcid.org/0000-0003-3174-3037","observed_orcids":["https://orcid.org/0000-0003-3174-3037"]},"institutions":[{"id":"https://openalex.org/I4210103132","display_name":"Hamad General Hospital","ror":"https://ror.org/01bgafn72","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210103132"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Amin Jayyousi","raw_affiliation_strings":["Academic Health System, Hamad General Hospital, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Health System, Hamad General Hospital, Doha, Qatar","institution_ids":["https://openalex.org/I4210103132","https://openalex.org/I49828101"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5005726509"],"corresponding_institution_ids":["https://openalex.org/I165951966","https://openalex.org/I4210165735"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.3205,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.80488093,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"22","issue":"12","first_page":"2287","last_page":"2294"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9670000076293945},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9620000123977661},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.8479999899864197},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9539999961853027},{"id":"https://openalex.org/keywords/multiple-daily-injections","display_name":"multiple daily insulin injections","score":0.8849999904632568},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9520000219345093},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.9409999847412109},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9279999732971191},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.765999972820282},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9739999771118164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8505887985229492},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.7766926288604736},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.7694250345230103},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7378862500190735},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7240036725997925},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.6999214291572571},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6563717722892761},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.633507251739502},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.632335364818573},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4919449985027313},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4648657441139221},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.4457712769508362},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.4266073405742645},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.1914430856704712},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11144977807998657}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000085002","descriptor_name":"Glycemic Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011780","descriptor_name":"Qatar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.14153","doi":"https://doi.org/10.1111/dom.14153","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.14153","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:32729222","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32729222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W19707534","https://openalex.org/W1508738408","https://openalex.org/W1994768261","https://openalex.org/W2029228033","https://openalex.org/W2041883787","https://openalex.org/W2059338882","https://openalex.org/W2060716197","https://openalex.org/W2061524651","https://openalex.org/W2062560800","https://openalex.org/W2068488844","https://openalex.org/W2095855723","https://openalex.org/W2105426804","https://openalex.org/W2109728760","https://openalex.org/W2128439162","https://openalex.org/W2140183516","https://openalex.org/W2170932033","https://openalex.org/W2572847517","https://openalex.org/W2752336761","https://openalex.org/W2775457770","https://openalex.org/W2791007077","https://openalex.org/W2892421153"],"related_works":["https://openalex.org/W2572847517","https://openalex.org/W4392581833","https://openalex.org/W2734042077","https://openalex.org/W2809562798","https://openalex.org/W2775457770","https://openalex.org/W2098895642","https://openalex.org/W1865158014","https://openalex.org/W2069665789","https://openalex.org/W2125848783","https://openalex.org/W1897237112"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"examine":[2],"the":[3,78,110,113,121,152,158,172,186],"long-term":[4],"efficacy":[5],"of":[6,102,109,163,249],"thiazolidinedione":[7],"plus":[8,34,88],"a":[9,62,129,138,235,246],"glucagon-like":[10],"peptide-1":[11],"receptor":[12],"agonist":[13],"versus":[14],"basal-bolus":[15],"insulin":[16,95,146,173,183,189,202,218,239],"on":[17,32,227],"glycaemic":[18,164],"control":[19,165],"and":[20,41,53,72,148,211,217,241],"beta-cell":[21],"function":[22],"in":[23,115,132,151,171,188,223,238,243],"patients":[24,43],"with":[25,44,191,201,245],"poorly":[26,45,224],"controlled":[27,46,225],"type":[28],"2":[29],"diabetes":[30],"(T2D)":[31],"metformin":[33],"sulphonylurea.":[35],"MATERIALS":[36],"AND":[37],"METHODS:":[38],"Three":[39],"hundred":[40],"thirty-one":[42],"T2D":[47,226],"were":[48,54,82],"recruited":[49],"over":[50],"3":[51],"years":[52],"followed":[55],"for":[56],"an":[57,100],"additional":[58],"year.":[59],"Subjects":[60],"received":[61],"75":[63],"g":[64],"oral":[65,229],"glucose":[66],"tolerance":[67],"test":[68],"(OGTT)":[69],"at":[70,73,117],"baseline":[71,79],"study":[74,111,118],"end.":[75],"After":[76],"completing":[77],"OGTT,":[80],"subjects":[81,150],"randomized":[83],"to":[84,98],"receive":[85],"either":[86],"pioglitazone":[87],"weekly":[89],"exenatide":[90],"(combination":[91],"therapy)":[92,97],"or":[93],"basal/bolus":[94],"(insulin":[96],"maintain":[99],"HbA1c":[101,116,222,244],"less":[103],"than":[104,145,169,200],"7.0%.":[105],"The":[106],"primary":[107],"outcome":[108],"was":[112,194],"difference":[114],"end":[119],"between":[120],"two":[122],"treatment":[123],"groups.":[124],"RESULTS:":[125],"Both":[126,180,214],"therapies":[127,181],"caused":[128,137,207],"robust":[130],"decrease":[131,242],"HbA1c.":[133],"However,":[134,185,231],"combination":[135,153,192,215,232],"therapy":[136,154,174,193,203,206,216,219,233],"greater":[139,196,236],"decrement":[140],"(-1.1%,":[141],"P":[142],"<":[143,167,178,198],".0001)":[144],"therapy,":[147],"more":[149,208],"group":[155,175],"(86%)":[156],"achieved":[157],"American":[159],"Diabetes":[160],"Association":[161],"goal":[162],"(HbA1c":[166],"7.0%)":[168],"those":[170],"(44%)":[176],"(P":[177,197],".0001).":[179],"improved":[182],"secretion.":[184],"improvement":[187,237],"secretion":[190,240],"2.5-fold":[195],".001)":[199],"(50%).":[204],"Insulin":[205],"weight":[209],"gain":[210],"hypoglycaemia.":[212,250],"CONCLUSION:":[213],"effectively":[220],"reduced":[221],"multiple":[228],"agents.":[230],"produced":[234],"lower":[247],"risk":[248]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2020-08-03T00:00:00"}